UniQure Prices 4.4 Mln Offering At $17/Share, Stock Down In Pre-Market
Wednesday announced the pricing of underwritten public offering of around 4.4 million shares at $17 per share, ...
manilatimes1h
Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are transformational for patients, today ...
uniQure Inc.: uniQure Announces Pricing of its Public Offering
LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
uniQure Announces Pricing of its Public Offering
LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
uniQure announces ordinary share, warrant offering, no amount given
Qure (QURE) announced that it has commenced an underwritten public offering of its ordinary shares and pre-funded warrants to purchase its ...
uniQure Announces Proposed Public Offering
LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
uniQure files automatic mixed securities shelf
EST uniQure (QURE) files automatic mixed securities shelfStay Ahead of the Market:Discover outperforming stocks and invest smarter with ...
uniQure price target raised to $24 from $20 at RBC Capital
RBC Capital analyst Luca Issi raised the firm’s price target on uniQure (QURE) to $24 from $20 and keeps an Outperform rating on the shares as ...
SA Asks: Which biotechs are most likely to be acquired near-term?
Last year's first quarter saw a flurry of biotech takeover deals, starting off with Johnson & Johnson (JNJ)/Ambrx, Merck (MRK)/Harpoon, GSK (GSK)/Aiolos and Novartis(NVS)/Calypso in early January.
uniQure (NASDAQ:QURE) Shares Gap Down – Here’s What Happened
Qure (NASDAQ:QURE – Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $18.05, but opened at $17.55. uniQure shares last traded at $17.73, with ...